Cord blood-derived biologics lead to robust axonal regeneration in benzalkonium chloride-injured mouse corneas by modulating the Il-17 pathway and neuropeptide Y.

Ruojing HuangCaiying SuNa ZhangCongying ShiGuangming PuYong DingWei WeiJian-Su Chen

Published in: Molecular medicine (Cambridge, Mass.) (2024)

Cord blood-derived therapeutics are feasible options for overcoming the sustained injuries induced by BAK in the cornea. They also have potential applications in areas where axonal regeneration is required.

Keyphrases

cord blood
stem cells
spinal cord injury
small molecule
signaling pathway
optic nerve
risk assessment